TY  - CONF

T1  - Time to first skeletal-related event (SRE) with radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases: ALSYMPCA trial stratification factors analysis

JO  - EUROPEAN JOURNAL OF CANCER

PY  - 2013/09/01

AU  - Coleman R

AU  - Fossa S

AU  - Chodacki A

AU  - Wedel S

AU  - Bruland O

AU  - Staudacher K

AU  - Garcia-Vargas J

AU  - Sartor O

ED  - 

VL  - 49

SP  - S688

EP  - S688

Y2  - 2025/10/10

ER  -